New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Scientists identify new 'regulatory' function of learning and memory gene common to all mammalian brain cells

Scientists identify new 'regulatory' function of learning and memory gene common to all mammalian brain cells

byJohns Hopkins University School of MedicineNeuron showing SynGAP (green) binding to PSD-95 at synapses. Credit: Yoichi Araki and Rick Huganir, Johns Hopkins MedicineJohns Hopkins Medicine neur
Neurology April 22,2024
Scientists identify new 'regulatory' function of learning and memory gene common to all mammalian brain cells

Scientists identify new 'regulatory' function of learning and memory gene common to all mammalian brain cells

byJohns Hopkins University School of MedicineNeuron showing SynGAP (green) binding to PSD-95 at synapses. Credit: Yoichi Araki and Rick Huganir, Johns Hopkins MedicineJohns Hopkins Medicine neur
Neurology April 22,2024
Web-based resource provides precise classification of dual genome variants of primary mitochondrial disease

Web-based resource provides precise classification of dual genome variants of primary mitochondrial disease

by Ben Leach,Children's Hospital of PhiladelphiaCredit: Pixabay/CC0 Public DomainA multi-institutional team of researchers led by teams at Children's Hospital Los Angeles and Children&#3
Pediatrics April 22,2024
Web-based resource provides precise classification of dual genome variants of primary mitochondrial disease

Web-based resource provides precise classification of dual genome variants of primary mitochondrial disease

by Ben Leach,Children's Hospital of PhiladelphiaCredit: Pixabay/CC0 Public DomainA multi-institutional team of researchers led by teams at Children's Hospital Los Angeles and Children&#3
Pediatrics April 22,2024
Caffeine intake interacts with Asian gene variants in Parkinson's disease, may lower risk

Caffeine intake interacts with Asian gene variants in Parkinson's disease, may lower risk

bySingHealthComparing ORs for PD stratified by genetic carrier status at LRRK2 risk loci and caffeine consumption. a. Comparing ORs for PD stratified by genetic carrier status at S1647T loci and
Neurology April 22,2024
Caffeine intake interacts with Asian gene variants in Parkinson's disease, may lower risk

Caffeine intake interacts with Asian gene variants in Parkinson's disease, may lower risk

bySingHealthComparing ORs for PD stratified by genetic carrier status at LRRK2 risk loci and caffeine consumption. a. Comparing ORs for PD stratified by genetic carrier status at S1647T loci and
Neurology April 22,2024
Major pathologic response to neoadjuvant pembrolizumab in advanced melanoma trial exceeds 50%

Major pathologic response to neoadjuvant pembrolizumab in advanced melanoma trial exceeds 50%

by SWOG Cancer Research NetworkCredit: CC0 Public DomainIn exploratory analyses of results from the SWOG S1801 trial in patients with stage III-IV resectable melanoma, researchers saw a major patholog
Oncology April 22,2024
Major pathologic response to neoadjuvant pembrolizumab in advanced melanoma trial exceeds 50%

Major pathologic response to neoadjuvant pembrolizumab in advanced melanoma trial exceeds 50%

by SWOG Cancer Research NetworkCredit: CC0 Public DomainIn exploratory analyses of results from the SWOG S1801 trial in patients with stage III-IV resectable melanoma, researchers saw a major patholog
Oncology April 22,2024
Few with CRC in sub-Saharan Africa receive guideline-concordant care

Few with CRC in sub-Saharan Africa receive guideline-concordant care

by Elana GotkineFewer than one in 20 patients diagnosed with colorectal cancer (CRC) in Sub-Saharan Africa (SSA) receive guideline-concordant treatment, according to a study published in the September
Oncology April 22,2024
Few with CRC in sub-Saharan Africa receive guideline-concordant care

Few with CRC in sub-Saharan Africa receive guideline-concordant care

by Elana GotkineFewer than one in 20 patients diagnosed with colorectal cancer (CRC) in Sub-Saharan Africa (SSA) receive guideline-concordant treatment, according to a study published in the September
Oncology April 22,2024
Evolutionary origin of mysterious immune system molecule in humans revealed

Evolutionary origin of mysterious immune system molecule in humans revealed

by Ashley WennersHerron,Pennsylvania State UniversityThe Joining chain shares three characteristics with the CXCL chemokine genes, including the same number of exons, which encode the protein, a
Immunology & Rheumatology April 22,2024
Evolutionary origin of mysterious immune system molecule in humans revealed

Evolutionary origin of mysterious immune system molecule in humans revealed

by Ashley WennersHerron,Pennsylvania State UniversityThe Joining chain shares three characteristics with the CXCL chemokine genes, including the same number of exons, which encode the protein, a
Immunology & Rheumatology April 22,2024
Stem cell reserves found in the stomach have implications for the genesis of gastric cancer

Stem cell reserves found in the stomach have implications for the genesis of gastric cancer

by Agency for Science, Technology and Research (A*STAR), SingaporeThe study revealed that Lgr5-expressing chief cells in the corpus glands can become gastric cancer precursors. Credit: Springer N
Oncology April 22,2024
Stem cell reserves found in the stomach have implications for the genesis of gastric cancer

Stem cell reserves found in the stomach have implications for the genesis of gastric cancer

by Agency for Science, Technology and Research (A*STAR), SingaporeThe study revealed that Lgr5-expressing chief cells in the corpus glands can become gastric cancer precursors. Credit: Springer N
Oncology April 22,2024
AZD6738 found to slow some types of children's tumor growth in mouse models

AZD6738 found to slow some types of children's tumor growth in mouse models

by Bob Yirka , Medical XpressCredit: CC0 Public Domain(Medical Xpress)—A team of researchers from the U.S., Germany and Japan has found that the chemical AZD6738 was able to slow some childhood type t
Oncology April 22,2024
AZD6738 found to slow some types of children's tumor growth in mouse models

AZD6738 found to slow some types of children's tumor growth in mouse models

by Bob Yirka , Medical XpressCredit: CC0 Public Domain(Medical Xpress)—A team of researchers from the U.S., Germany and Japan has found that the chemical AZD6738 was able to slow some childhood type t
Oncology April 22,2024
Genetic discovery reveals who can benefit from preterm birth therapy

Genetic discovery reveals who can benefit from preterm birth therapy

byUniversity of California, San FranciscoStudy design shown in the flowchart. Credit:Science Advances(2024). DOI: 10.1126/sciadv.adk1057A UC San Francisco-led study has for the first
OB & GYN April 22,2024
Genetic discovery reveals who can benefit from preterm birth therapy

Genetic discovery reveals who can benefit from preterm birth therapy

byUniversity of California, San FranciscoStudy design shown in the flowchart. Credit:Science Advances(2024). DOI: 10.1126/sciadv.adk1057A UC San Francisco-led study has for the first
OB & GYN April 22,2024
New framework for using AI in health care considers medical knowledge, practices, procedures, values

New framework for using AI in health care considers medical knowledge, practices, procedures, values

by Carnegie Mellon UniversityCredit: Pixabay/CC0 Public DomainHealth care organizations are looking to artificial intelligence (AI) tools to improve patient care, but their translation into clini
Oncology April 22,2024
New framework for using AI in health care considers medical knowledge, practices, procedures, values

New framework for using AI in health care considers medical knowledge, practices, procedures, values

by Carnegie Mellon UniversityCredit: Pixabay/CC0 Public DomainHealth care organizations are looking to artificial intelligence (AI) tools to improve patient care, but their translation into clini
Oncology April 22,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com